TGFB1 and arthritic joint disease: Thus, one effect of immunization with mBSA+IFA in the presence of IFN-α may be development of mBSA-specific tolerogenic cells, which, on intraarticular injection, are reactivated to produce TGF-β (Figure 6B), which prevents activation of mBSA-induced arthritis.